What is it about?
As nucleotide analogues, thiopurines efficiently maintain control of immune mediated disease. The indication for a large use of thiopurines in the maintenance of inflammatory bowel disease (IBD) has come of age based on economic and medical issues: (1) IBD management costs fall to nadir during remission periods; (2) Patients’ quality of life is best when the IBD is in control. Shown to achieve mucosal healing, , thiopurines have now entered modern treat-to-target IBD algorithms.
Photo by Thought Catalog on Unsplash
Why is it important?
This paper provides definitive summary that thiopurines are still the drugs to beat in IBD in terms of: 1) Cost containment; 2) Mucosal Healing; 3) Reduction of colon neoplastic transformation.
Read the Original
This page is a summary of: A Concise History of Thiopurines for Inflammatory Bowel Disease: From Anecdotal Reporting to Treat-to-Target Algorithms, Reviews on Recent Clinical Trials, January 2019, Bentham Science Publishers, DOI: 10.2174/1574887113666180910120959.
You can read the full text:
The following have contributed to this page